Cargando…

Beneficial behavioral effects of chronic cerebral dopamine neurotrophic factor (CDNF) infusion in the N171-82Q transgenic model of Huntington’s disease

Huntington’s disease (HD) is a progressive inherited neurological disease characterized by the degeneration of basal ganglia and the accumulation of mutant huntingtin (mHtt) aggregates in specific brain areas. Currently, there is no treatment for halting the progression of HD. Cerebral dopamine neur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stepanova, P., Kumar, D., Cavonius, K., Korpikoski, J., Sirjala, J., Lindholm, D., Voutilainen, M. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941578/ https://www.ncbi.nlm.nih.gov/pubmed/36807563 http://dx.doi.org/10.1038/s41598-023-28798-4

Ejemplares similares

Cerebral dopamine neurotrophic factor (CDNF) protects against quinolinic acid-induced toxicity in in vitro and in vivo models of Huntington’s disease
por: Stepanova, P., et al.
Publicado: (2020)

CDNF and MANF in the brain dopamine system and their potential as treatment for Parkinson’s disease
por: Pakarinen, Emmi, et al.
Publicado: (2023)

Intrastriatally Infused Exogenous CDNF Is Endocytosed and Retrogradely Transported to Substantia Nigra
por: Mätlik, Kert, et al.
Publicado: (2017)

Association between cerebral dopamine neurotrophic factor (CDNF) 2 polymorphisms and schizophrenia susceptibility and symptoms in the Han Chinese population
por: Yang, Yongfeng, et al.
Publicado: (2018)

Human-Specific Regulation of Neurotrophic Factors MANF and CDNF by microRNAs
por: Konovalova, Julia, et al.
Publicado: (2021)

Comparative Analysis of the Effects of Neurotrophic Factors CDNF and GDNF in a Nonhuman Primate Model of Parkinson’s Disease
por: Garea-Rodríguez, Enrique, et al.
Publicado: (2016)

Evidence for an Additive Neurorestorative Effect of Simultaneously Administered CDNF and GDNF in Hemiparkinsonian Rats: Implications for Different Mechanism of Action
por: Voutilainen, Merja H., et al.
Publicado: (2017)

Cerebral Dopamine Neurotrophic Factor (CDNF) Has Neuroprotective Effects against Cerebral Ischemia That May Occur through the Endoplasmic Reticulum Stress Pathway
por: Zhang, Geng-Lin, et al.
Publicado: (2018)

CDNF and MANF regulate ER stress in a tissue-specific manner
por: Pakarinen, Emmi, et al.
Publicado: (2022)

CDNF rescues motor neurons in models of amyotrophic lateral sclerosis by targeting endoplasmic reticulum stress
por: De Lorenzo, Francesca, et al.
Publicado: (2023)

Iron activates microglia and directly stimulates indoleamine-2,3-dioxygenase activity in the N171-82Q mouse model of Huntington’s disease
por: Donley, David W., et al.
Publicado: (2021)

Characterization of the Structural and Functional Determinants of MANF/CDNF in Drosophila In Vivo Model
por: Lindström, Riitta, et al.
Publicado: (2013)

Characterization of CDNF-Secreting ARPE-19 Cell Clones for Encapsulated Cell Therapy
por: Galli, Emilia, et al.
Publicado: (2019)

Cerebral dopamine neurotrophic factor protects and repairs dopamine neurons by novel mechanism
por: Lindholm, Päivi, et al.
Publicado: (2021)

CDNF Protein Therapy in Parkinson’s Disease
por: Huttunen, Henri J., et al.
Publicado: (2019)

Transplantation of human embryonic stem cells alleviates motor dysfunction in AAV2-Htt171-82Q transfected rat model of Huntington’s disease
por: Islam, Jaisan, et al.
Publicado: (2021)

Protection of dopamine neurons by CDNF and neurturin variant N4 against MPP(+) in dissociated cultures from rat mesencephalon
por: Jaumotte, Juliann D., et al.
Publicado: (2021)

CDNF Interacts with ER Chaperones and Requires UPR Sensors to Promote Neuronal Survival
por: Eesmaa, Ave, et al.
Publicado: (2022)

Effects of the Pimelic Diphenylamide Histone Deacetylase Inhibitor HDACi 4b on the R6/2 and N171-82Q Mouse Models of Huntington’s Disease
por: Chen, Jane Y., et al.
Publicado: (2013)

Correction: Effects of the Pimelic Diphenylamide Histone Deacetylase Inhibitor HDACi 4b on the R6/2 and N171-82Q Mouse Models of Huntington’s Disease
Publicado: (2017)

A Comparative Analysis of the Molecular Features of MANF and CDNF
por: Norisada, Junpei, et al.
Publicado: (2016)

Trophic Factors in Inflammation and Regeneration: The Role of MANF and CDNF
por: Sousa-Victor, Pedro, et al.
Publicado: (2018)

Adeno-Associated Viral Vector Serotype DJ-Mediated Overexpression of N171-82Q-Mutant Huntingtin in the Striatum of Juvenile Mice Is a New Model for Huntington’s Disease
por: Jang, Minhee, et al.
Publicado: (2018)

Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease
por: Bäck, Susanne, et al.
Publicado: (2013)

Transient transfection of human CDNF gene reduces the 6-hydroxydopamine-induced neuroinflammation in the rat substantia nigra
por: Nadella, Rasajna, et al.
Publicado: (2014)

An Optimization of AAV-82Q-Delivered Rat Model of Huntington’s Disease
por: So, Kyoung-Ha, et al.
Publicado: (2020)

Brain-Derived Neurotrophic Factor in Patients with Huntington's Disease
por: Zuccato, Chiara, et al.
Publicado: (2011)

The Effect of RADA16-I and CDNF on Neurogenesis and Neuroprotection in Brain Ischemia-Reperfusion Injury
por: Liu, Xingyu, et al.
Publicado: (2022)

The Role of Dopamine and Glutamate Modulation in Huntington Disease
por: Mittal, Sumeer K., et al.
Publicado: (2013)

At PS171 (ASTERIX)
Publicado: (1983)

Huntington’s Disease: From Mutant Huntingtin Protein to Neurotrophic Factor Therapy
por: Sari, Youssef
Publicado: (2011)

Functional analysis of brain derived neurotrophic factor (BDNF) in Huntington’s disease
por: Zhou, Zhike, et al.
Publicado: (2021)

In vivo Dopamine Efflux is Decreased in Striatum of both Fragment (R6/2) and Full-Length (YAC128) Transgenic Mouse Models of Huntington's Disease
por: Callahan, Joshua W., et al.
Publicado: (2011)

Recombinant AAV8-mediated intrastriatal gene delivery of CDNF protects rats against methamphetamine neurotoxicity
por: Wang, Lizheng, et al.
Publicado: (2017)

171th RB Meeting
Publicado: (2005)

Memorandum: PS171 experiment
por: Klempt, E
Publicado: (1982)

Cerebral Dopamine Neurotrophic Factor Diffuses Around the Brainstem and Does Not Undergo Anterograde Transport After Injection to the Substantia Nigra
por: Albert, Katrina, et al.
Publicado: (2019)

Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) Elevates Stimulus-Evoked Release of Dopamine in Freely-Moving Rats
por: Renko, Juho-Matti, et al.
Publicado: (2018)

Longitudinal home-cage automated assessment of climbing behavior shows sexual dimorphism and aging-related decrease in C57BL/6J healthy mice and allows early detection of motor impairment in the N171-82Q mouse model of Huntington’s disease
por: Bains, Rasneer S., et al.
Publicado: (2023)

Dantrolene is neuroprotective in Huntington's disease transgenic mouse model
por: Chen, Xi, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_cs6440gges0d36bfbu39i23pfn